{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T04:19:28Z","timestamp":1768537168735,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"West of Scotland Virology Centre"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.drugpo.2019.01.008","type":"journal-article","created":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T01:37:15Z","timestamp":1548553035000},"page":"30-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Emergence of Novel Psychoactive Substance injecting associated with rapid rise in the population prevalence of hepatitis C virus"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6047-2400","authenticated-orcid":false,"given":"Andrew","family":"McAuley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avril","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon J.","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Munro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugpo.2019.01.008_bib0005","series-title":"Impact of the reduction in heroin supply between 2010 and 2011","author":"Ahmad","year":"2016"},{"issue":"10117","key":"10.1016\/j.drugpo.2019.01.008_bib0010","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(17)31869-X","article-title":"Morbidity and mortality in homeless individuals, prisoners, sex workers, and individuals with substance use disorders in high-income countries: A systematic review and meta-analysis","volume":"391","author":"Aldridge","year":"2018","journal-title":"The Lancet"},{"key":"10.1016\/j.drugpo.2019.01.008_bib0015","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.drugpo.2016.10.015","article-title":"From niche to stigma-headshops to prison: Exploring the rise and fall of synthetic cannabinoid use among young adults","volume":"40","author":"Blackman","year":"2017","journal-title":"The International Journal of Drug Policy"},{"issue":"3","key":"10.1016\/j.drugpo.2019.01.008_bib0020","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0376-8716(98)00028-3","article-title":"Self-report among injecting drug users: A review","volume":"51","author":"Darke","year":"1998","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2019.01.008_bib0025","series-title":"Health responses to new psychoactive substances","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2016"},{"key":"10.1016\/j.drugpo.2019.01.008_bib0030","series-title":"High-risk drug use and new psychoactive substances","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2017"},{"key":"10.1016\/j.drugpo.2019.01.008_bib0035","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1360-0443.2006.01316.x","article-title":"Substance abuse and dependence in prisoners: A systematic review","volume":"101","author":"Fazel","year":"2006","journal-title":"Addiction"},{"issue":"40","key":"10.1016\/j.drugpo.2019.01.008_bib0040","article-title":"Injection of new psychoactive substance snow blow associated with recently acquired HIV infections among homeless people who inject drugs in Dublin, Ireland, 2015","volume":"20","author":"Giese","year":"2015","journal-title":"Euro Surveillance"},{"key":"10.1016\/j.drugpo.2019.01.008_bib0045","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1017\/S095026881500271X","article-title":"Staphylococcus aureus bacteraemia associated with injected new psychoactive substances","volume":"144","author":"Griffith","year":"2016","journal-title":"Epidemiology and Infection"},{"key":"10.1016\/j.drugpo.2019.01.008_bib0050","series-title":"Estimating the national and local prevalence of problem drug misuse in Scotland","author":"Hay","year":"2009"},{"key":"10.1016\/j.drugpo.2019.01.008_bib0055","series-title":"The Needle Exchange Surveillance Initiative (NESI): Prevalence of blood-borne viruses and injecting risk behaviours among people who inject drugs (PWID) attending injecting equipment provision (IEP) services in Scotland, 2008\u201309 to 2015\u201316","author":"Health Protection Scotland","year":"2017"},{"issue":"19","key":"10.1016\/j.drugpo.2019.01.008_bib0060","article-title":"Is the recent emergence of mephedrone injecting in the United Kingdom associated with elevated risk behaviours and blood borne virus infection?","volume":"21","author":"Hope","year":"2016","journal-title":"Euro Surveillance"},{"key":"10.1016\/j.drugpo.2019.01.008_bib0065","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1365-2893.2010.01297.x","article-title":"Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots","volume":"18","author":"Hope","year":"2011","journal-title":"Journal of Viral Hepatitis"},{"key":"10.1016\/j.drugpo.2019.01.008_bib0070","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2174\/1570159X13666141210224137","article-title":"Synthetic cathinones: A new public health problem","volume":"13","author":"Karila","year":"2015","journal-title":"Current Neuropharmacology"},{"key":"10.1016\/j.drugpo.2019.01.008_bib0075","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13643-016-0375-5","article-title":"The prevalence of novel psychoactive substances (NPS) use in non-clinical populations: A systematic review protocol","volume":"5","author":"Khaled","year":"2016","journal-title":"Systematic Reviews"},{"issue":"2","key":"10.1016\/j.drugpo.2019.01.008_bib0080","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/0036933016649871","article-title":"The experience of an increase in the injection of ethylphenidate in Lothian April 2014\u2013March 2015","volume":"61","author":"Lafferty","year":"2016","journal-title":"Scottish Medical Journal"},{"issue":"2","key":"10.1016\/j.drugpo.2019.01.008_bib0085","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2471\/BLT.12.108282","article-title":"Mortality among people who inject drugs: A systematic review and meta-analysis","volume":"91","author":"Mathers","year":"2013","journal-title":"Bulletin of the World Health Organization"},{"issue":"5","key":"10.1016\/j.drugpo.2019.01.008_bib0090","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.drugpo.2014.10.010","article-title":"Mortality related to novel psychoactive substances in Scotland, 2012: An exploratory study","volume":"26","author":"McAuley","year":"2015","journal-title":"The International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2019.01.008_bib0095","series-title":"Drug-related deaths in Scotland in 2017","author":"National Records of Scotland","year":"2018"},{"key":"10.1016\/j.drugpo.2019.01.008_bib0100","series-title":"Estimating the national and local prevalence of problem drug use in Scotland 2012\/13","author":"NHS National Services Scotland","year":"2016"},{"key":"10.1016\/j.drugpo.2019.01.008_bib0105","series-title":"Overview of initial assessments for specialist drug treatment 2015\/16","author":"NHS National Services Scotland","year":"2017"},{"key":"10.1016\/j.drugpo.2019.01.008_bib0110","series-title":"Drug-related hospital statistics Scotland 2016\/17","author":"NHS National Services Scotland","year":"2017"},{"key":"10.1016\/j.drugpo.2019.01.008_bib0115","series-title":"Injecting equipment provision in Scotland 2015\/16","author":"NHS National Services Scotland","year":"2017"},{"issue":"11","key":"10.1016\/j.drugpo.2019.01.008_bib0120","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.puhe.2013.08.018","article-title":"Ongoing outbreak of multiple blood-borne infections in injecting drug users in Romania","volume":"127","author":"Oprea","year":"2013","journal-title":"Public Health"},{"issue":"9","key":"10.1016\/j.drugpo.2019.01.008_bib0125","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/sim.6047","article-title":"Incomplete contingency tables with censored cells with application to estimating the number of people who inject drugs in Scotland","volume":"33","author":"Overstall","year":"2014","journal-title":"Statistics in Medicine"},{"key":"10.1016\/j.drugpo.2019.01.008_bib0130","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1128\/JCM.01229-07","article-title":"Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates","volume":"46","author":"Page-Shafer","year":"2008","journal-title":"Journal of Clinical Microbiology"},{"issue":"8","key":"10.1016\/j.drugpo.2019.01.008_bib0135","doi-asserted-by":"crossref","first-page":"e104515","DOI":"10.1371\/journal.pone.0104515","article-title":"Rapid decline in HCV incidence among people who inject drugs associated with national scale-up in coverage of a combination of harm reduction interventions","volume":"9","author":"Palmateer","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.drugpo.2019.01.008_bib0140","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1111\/bcp.13672","article-title":"New drug controls and reduced hospital presentations due to novel psychoactive substances in Edinburgh","volume":"84","author":"Pettie","year":"2018","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.drugpo.2019.01.008_bib0145","series-title":"Homelessness: Applying all our health","author":"Public Health England","year":"2018"},{"key":"10.1016\/j.drugpo.2019.01.008_bib0150","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.drugalcdep.2015.10.034","article-title":"Veni, vidi, vici: The appearance and dominance of new psychoactive substances among new participants at the largest needle exchange program in Hungary between 2006 and 2014","volume":"158","author":"R\u00e1cz","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2019.01.008_bib0155","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.drugpo.2016.10.003","article-title":"Adding spice to the porridge: The development of a synthetic cannabinoid market in an English prison","volume":"40","author":"Ralphs","year":"2017","journal-title":"The International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2019.01.008_bib0160","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/add.13439","article-title":"Can new psychoactive substances be regulated effectively? An assessment of the British Psychoactive Substances Bill","volume":"112","author":"Reuter","year":"2017","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.drugpo.2019.01.008_bib0165","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0955-3959(02)00007-5","article-title":"The \u2018risk environment\u2019: A framework for understanding and reducing drug-related harm","volume":"13","author":"Rhodes","year":"2009","journal-title":"The International Journal of Drug Policy"},{"issue":"5","key":"10.1016\/j.drugpo.2019.01.008_bib0170","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1080\/02791072.2017.1361560","article-title":"Examination of synthetic cannabinoid and cathinone use among a drug-using offender sample, 2013\u20132015","volume":"49","author":"Smith","year":"2017","journal-title":"Journal of Psychoactive Drugs"},{"issue":"7","key":"10.1016\/j.drugpo.2019.01.008_bib0175","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3109\/10826084.2015.978672","article-title":"Emerging risks due to new injecting patterns in Hungary during austerity times","volume":"50","author":"Tarj\u00e1n","year":"2015","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.drugpo.2019.01.008_bib0180","doi-asserted-by":"crossref","first-page":"i6848","DOI":"10.1136\/bmj.i6848","article-title":"Novel psychoactive substances: Types, mechanisms of action, and effects","volume":"356","author":"Tracy","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.drugpo.2019.01.008_bib0185","series-title":"The challenge of new psychoactive substances","author":"United Nations Office on Drugs and Crime","year":"2013"},{"key":"10.1016\/j.drugpo.2019.01.008_bib0190","series-title":"Combating Hepatitis B and C to reach elimination by 2030","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.drugpo.2019.01.008_bib0195","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1111\/add.13898","article-title":"Assessing the impact of a temporary class drug order on ethylphenidate-related infections among people who inject drugs in Lothian, Scotland: An interrupted time\u2013series analysis","volume":"112","author":"Yeung","year":"2017","journal-title":"Addiction"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395919300167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395919300167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T17:58:12Z","timestamp":1553018292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395919300167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":39,"alternative-id":["S0955395919300167"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2019.01.008","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emergence of Novel Psychoactive Substance injecting associated with rapid rise in the population prevalence of hepatitis C virus","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2019.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}